MODULATORS OF MULTI-DRUG RESISTANCES

The present invention relates to imidazole derivatives having formula 1 (see fig. I) wherein: R1 is selected from the group consisting of: mono-,di-,and tri-substituted phenyl or thienyl, the substituents are selected from the group consisting of: (i) substituted C1-6 alkyl, substituted C2-6 alkylox...

Full description

Saved in:
Bibliographic Details
Main Authors MJALLI, ADNAN M.M, SARSHAR, SEPEHR
Format Patent
LanguageEnglish
French
Published 25.10.1998
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to imidazole derivatives having formula 1 (see fig. I) wherein: R1 is selected from the group consisting of: mono-,di-,and tri-substituted phenyl or thienyl, the substituents are selected from the group consisting of: (i) substituted C1-6 alkyl, substituted C2-6 alkyloxy, wherein the substituents are selected from the group consisting of hydrogen or C1-6 alkoxy; (ii) C1-11 CO2R5, trans- CH=CHCO2R5, wherein R5 is C1-11 alkyl, or phenyl C1-11 alkyl; R2 and R3 are mono-, di, and tri-substituted phenyl wherein the substituents are independently selected from: (i) halo; (ii) C1-6 alkyl-amino, or di(C1-6 alkyl)amino, and R4 is hydrogen. These compounds are useful for restoring the sensitivity of multidrug resistant cells to cancer chemotherapeutic agents.
AbstractList The present invention relates to imidazole derivatives having formula 1 (see fig. I) wherein: R1 is selected from the group consisting of: mono-,di-,and tri-substituted phenyl or thienyl, the substituents are selected from the group consisting of: (i) substituted C1-6 alkyl, substituted C2-6 alkyloxy, wherein the substituents are selected from the group consisting of hydrogen or C1-6 alkoxy; (ii) C1-11 CO2R5, trans- CH=CHCO2R5, wherein R5 is C1-11 alkyl, or phenyl C1-11 alkyl; R2 and R3 are mono-, di, and tri-substituted phenyl wherein the substituents are independently selected from: (i) halo; (ii) C1-6 alkyl-amino, or di(C1-6 alkyl)amino, and R4 is hydrogen. These compounds are useful for restoring the sensitivity of multidrug resistant cells to cancer chemotherapeutic agents.
Author SARSHAR, SEPEHR
MJALLI, ADNAN M.M
Author_xml – fullname: MJALLI, ADNAN M.M
– fullname: SARSHAR, SEPEHR
BookMark eNrjYmDJy89L5WRQ8fV3CfVxDPEPClbwd1PwDfUJ8dR1CQp1VwhyDfYMDnH0c3YN5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8c6ORkYG5uamxo6GxkQoAQAtwyRw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate MODIFIEURS DE LA RESISTANCE A PLUSIEURS MEDICAMENTS
Edition 6
ExternalDocumentID CA2207753A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2207753A13
IEDL.DBID EVB
IngestDate Fri Jul 19 11:37:05 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2207753A13
Notes Application Number: CA19972207753
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19981025&DB=EPODOC&CC=CA&NR=2207753A1
ParticipantIDs epo_espacenet_CA2207753A1
PublicationCentury 1900
PublicationDate 19981025
PublicationDateYYYYMMDD 1998-10-25
PublicationDate_xml – month: 10
  year: 1998
  text: 19981025
  day: 25
PublicationDecade 1990
PublicationYear 1998
RelatedCompanies ONTOGEN CORPORATION
RelatedCompanies_xml – name: ONTOGEN CORPORATION
Score 2.4878
Snippet The present invention relates to imidazole derivatives having formula 1 (see fig. I) wherein: R1 is selected from the group consisting of: mono-,di-,and...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title MODULATORS OF MULTI-DRUG RESISTANCES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19981025&DB=EPODOC&locale=&CC=CA&NR=2207753A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV07T8MwED5VBQEbFBDlpQxVtojUiZN2iFBqJ7Soaao8ULeqeUldSkWD-PucraawwGbZkh8nf3dn-74zQA-xbNOiKDQ9o7ZmrlYIqWFJNL0amgT3s2D7iGiLmTVOzdcFXbRg3XBhZJ7QL5kcERGVI95rqa-3P5dYXMZW7p6yNVa9P_uJw9WioYuhvaQqHznePOQhUxlzmKvOIocQkevNcPGgdIRetC2iv7y3kSClbH9bFP8cjufY2aa-gFa56cApaz5e68BJsH_vxuIeertL6AUhT6duEkaxEvpKkE6Ticaj9EVBGU7iRHwyE1-B4nsJG2s43PKwtCVzDxMzrqGNJ_7yBpQcjTx6Tn3LIplpFOgVoc7K7YwOKr1fDWgXun92c_tP2x2cSUodql5C76Fdf3yWD2hT6-xRSuMbuIh2Ag
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1JT4NAFH5pqrHetGqsK4eGG5ECA_RADB1AUJaGxfRGypb00jYW49_3QUr1orfJTDJb5nvLzHzvAYwRywopioLjM6Jw0nKJkJqWAsdXU0nA89ywfZrfFr5sJ9Lrgix6sOq4MG2c0K82OCIiKke816283v5cYhnt38rdU7bCqs2zFWsGW3R0MdSXhDVmmjkPjICylGpUZ_1QE4Qm1puoo6N0hBa22oTZN99nDSll-1ujWGdwPMfO1vU59Mr1EAa0S7w2hBNv_96NxT30dhcw9gIjcfU4CCMmsBgvcWOHM8LkhcE9dKK4STITXQJjmTG1ORwuPSwtpfphYuIV9NHjL6-ByVHJo-U0kWUhk8QCrSKUWbmSEbXiJ5VKRjD6s5ubf9oeYWDHnpu6jv92C6ctvQ7FsEDuoF9_fJb3qF_r7KHdmW9nwHjy
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MODULATORS+OF+MULTI-DRUG+RESISTANCES&rft.inventor=MJALLI%2C+ADNAN+M.M&rft.inventor=SARSHAR%2C+SEPEHR&rft.date=1998-10-25&rft.externalDBID=A1&rft.externalDocID=CA2207753A1